2003
DOI: 10.1107/s1600536803004100
|View full text |Cite
|
Sign up to set email alerts
|

4-(4-Bromophenyl)-2,5-diethoxycarbonyl-6-methylthieno[2,3-b]pyridine

Abstract: Key indicatorsSingle-crystal X-ray study T = 293 K Mean '(C±C) = 0.008 A Ê R factor = 0.046 wR factor = 0.132 Data-to-parameter ratio = 9.6For details of how these key indicators were automatically derived from the article, see

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…3,4-DHPo and the 6-chloro-5-formyl-1,4-DHPs (Figure 6b) have become versatile intermediaries of other compounds (Figure 6). [26][27][28][76][77][78][79][80][81][82] Starting from b, more complex structures have been synthesized. 1,5-benzodiazepine fused to a dihydropyridine moiety (Figure 6c) have been prepared, and one derivative (JM-20, Figure 6c) has shown promising neuroprotective and antioxidant properties.…”
Section: Structural Characterizationmentioning
confidence: 99%
“…3,4-DHPo and the 6-chloro-5-formyl-1,4-DHPs (Figure 6b) have become versatile intermediaries of other compounds (Figure 6). [26][27][28][76][77][78][79][80][81][82] Starting from b, more complex structures have been synthesized. 1,5-benzodiazepine fused to a dihydropyridine moiety (Figure 6c) have been prepared, and one derivative (JM-20, Figure 6c) has shown promising neuroprotective and antioxidant properties.…”
Section: Structural Characterizationmentioning
confidence: 99%